SF3B1 and cancer: The loss of interaction between SF3B1 and SUGP1 due to cancer mutations in either SF3B1 or SUGP1 provides an explanation for why the mutant spliceosome fails to activate DHX15 for ATP hydrolysis required for canonical branch site selection.